HIV 1-2 Ag/Ab selective and combined detection by a new rapid point-of-care test


Submitted: 14 February 2014
Accepted: 14 February 2014
Published: 31 December 2010
Abstract Views: 822
PDF: 1078
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In order to reduce the window phase between time of human immunodeficiency virus (HIV) exposure and source’s results of laboratory investigations, we evaluated the analytical performance of a new point of care test for simultaneous detection of HIV Abs and HIV Ag.We tested 48 serum samples by HIV Combo Ag/Ab Abbott Diagnostic®, USA; by Western Blot Matrix HIV 1/2 Abbott®, USA and by the new POCT test HIV 1/2 Ag/Ab Combo Inverness Medical®, UK. Good concordance of results was recordered with analytical performance (sensitivity and specificity) and diagnostic accuracy of 100%.Thus this new test is ideal for rapid laboratory investigation when the time for appropriate prophylactic therapy is very important, such as found in exposure in the workplace.

Monari, M., Valaperta, S., Baldassarre, E., Assandri, R., & Montanelli, A. (2010). HIV 1-2 Ag/Ab selective and combined detection by a new rapid point-of-care test. Microbiologia Medica, 25(4). https://doi.org/10.4081/mm.2010.2412

Downloads

Download data is not yet available.

Citations